News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Dr. Evan Manolis Joins AcronGenomics Inc.'s Board of Directors
May 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GENEVA, Switzerland--(BUSINESS WIRE)--Acrongenomics Inc. (OTCBB:AGNM) a publicly traded life sciences company today announced that Dr. Evan Manolis has joined its board of directors and scientific committee.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Manufacturing
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
May 14, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Bayer, Leap, Atara Reduce Workforces Amid Strategic Reorganizations
May 14, 2025
·
204 min read
·
BioSpace Editorial Staff
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
May 14, 2025
·
2 min read
·
Heather McKenzie
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong
